| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | tacrolimus (Modigraf®) |
| Formulation | 0.2 mg and 1 mg granules for oral suspension |
| Reference number | 445 |
| Indication | Prophylaxis and treatment of transplant rejection in adult and paediatric kidney, liver or heart allograft |
| Company | Astellas Pharma Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 12/08/2009 |